CARBIDOPA-LEVODOPA-ENTACAPONE is a medication that combines three active ingredients to treat Parkinson's disease. Carbidopa helps prevent the breakdown of levodopa in the bloodstream, allowing more of it to reach the brain and be converted into dopamine. Levodopa is a precursor to dopamine and helps alleviate the symptoms of Parkinson's disease. Entacapone prolongs the effects of levodopa by inhibiting an enzyme that breaks it down. This combination medication helps improve motor function and reduce the symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty with movement.
ENTACAPONE is a medication used in the treatment of Parkinson's disease. It belongs to a class of drugs called COMT inhibitors, which work by increasing the levels of dopamine in the brain. This helps to improve motor symptoms such as tremors, stiffness, and slowness of movement. ENTACAPONE is typically used in combination with other medications for Parkinson's disease, such as levodopa/carbidopa, to enhance their effectiveness and prolong their duration of action. It is available in tablet form and is usually taken multiple times a day as prescribed by a healthcare professional.
ONGENTYS is a medication used to treat Parkinson's disease. It works by blocking a specific enzyme in the brain that breaks down dopamine, a neurotransmitter that is important for movement control. By increasing dopamine levels, ONGENTYS helps to improve motor symptoms such as tremors, stiffness, and slowness of movement. It is typically prescribed as an add-on therapy for patients who are already taking levodopa/carbidopa and experiencing "off" episodes, when their symptoms worsen. ONGENTYS comes in the form of tablets and is taken orally.
